ALYSSA COOGAN: Open Payments
NPI 1801302765 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,523 in 140 payments from 18 companies in 2025. Trend: 2023 $1,042 · 2024 $2,058 · 2025 $2,523
Food & beverage: $2,465Education: $58
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $485 |
| LEO Pharma Inc. | 16 | $420 |
| Janssen Biotech, Inc. | 19 | $223 |
| E.R. Squibb & Sons, L.L.C. | 9 | $174 |
| Regeneron Healthcare Solutions, Inc. | 6 | $173 |
| Galderma Laboratories, L.P. | 12 | $171 |
| Amgen Inc. | 3 | $160 |
| GENZYME CORPORATION | 6 | $135 |
| Incyte Corporation | 5 | $134 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
Products named: ADBRY, DUPIXENT, SKYRIZI, RINVOQ, TREMFYA, Sotyktu, OTEZLA, OPZELURA.
Industry payments across MA — which companies pay providers there.
